GRAIL, Inc. (GRAL)
GRAIL, Inc. (GRAL) from its SEC filings: 2025 revenue $147.2 million (+17% vs the year before), net margin -278%, free cash flow -$299.9 million. Insider trades, recent filings and a price chart. Free.
| Exchange | Nasdaq |
| Industry | Services-Medical Laboratories |
| Revenue (2025) | $147.2 million |
| Revenue growth | +17% |
| Net income | -$408.4 million |
| Net margin | -277.5% |
| Free cash flow | -$299.9 million |
| Diluted EPS | $-11.11 |
| Latest quarter (Q2 2026 (calendar)) revenue vs a year earlier | +26% |
| Cash | $55.6 million |
| Share count, 1 year | +24% |
| Fundamentals check | Mixed fundamentals |
Source: SEC EDGAR company filings (XBRL), updated 2026-10-24. Education only, not financial advice.